Latest News

January 11, 2018

Dr. Kabir Mody and Dr. Ghassan K. Abou-Alfa discuss genomic analyses and therapies for hepatocellular carcinoma.

Read more

January 11, 2018

Dr. Benjamin L. Solomon and Dr. Ignacio Garrido-Laguna discuss treatment strategies for pancreatic ductal adenocarcinoma.

Read more

January 11, 2018

Dr. Vivian E. Strong and Dr. Ryan C. Fields discuss standards of care for varying stages of gastric cancer.

Read more

January 11, 2018

Dr. Daphna Y. Spiegel et al review the role of adjuvant therapy and the current treatment landscape for rectal cancer.

Read more

January 11, 2018

Afsaneh Barzi, MD, and Vincent Chung, MD, FACP, answer a question posed by an attendee during a Best of ASCO® Meeting about the role of lenvatinib in the landscape of hepatocellular carcinoma treatment.

Read more
January 11, 2018

Dr. Paola Montenegro discusses recommended frontline therapies, pathways, and standard treatment possibilities for small bowel adenocarcinomas.

Read more
January 11, 2018

Pancreatic cystic neoplasms are categorized using the World Health Organization histologic classification and there are four major subtypes, which have varying malignant potential: serous, mucinous, intraductal papillary mucinous neoplasm, and solid pseudopapillary epithelial neoplasms.

Read more
January 11, 2018

Dr. Reham Abdel-Wahab discusses whether we should be testing all tumors for microsatellite instability score or DNA mismatch repair gene status.

Read more
January 11, 2018

Dr. Flavio G. Rocha reviews liver-directed therapy for advanced intrahepatic cholangiocarcinoma, which can be difficult to manage because of several factors including late diagnosis, early metastatic spread, and potential for liver dysfunction. 

Read more

January 11, 2018

Dr. Davendra P. S. Sohal discusses the management of metastatic pancreatic cancer, specifically the advances made since ASCO issued guidelines in 2016 for management of metastatic pancreatic cancer and the future direction for treatment.

Read more
January 11, 2018

Mohamed E. Salem, MD; Ahmed O. Kaseb, MD; and Sunil Krishnan, MD,discuss whether they would consider adding radiation therapy after 6 months of adjuvant capecitabine for a positive microscopic margin in resected biliary tract cancer.

Read more
January 11, 2018

The Gastrointestinal Cancers Symposium Clinical Corner allows expert physicians to answer questions posed by an attendee during previous Best of ASCO Meetings.

Read more

January 12, 2017

Drs. Geoffrey Y. Ku and David H. Ilson discuss recent phase III studies that have attempted to refine the role of perioperative strategies in the treatment of gastric cancer.

Read more

January 12, 2017

As the worldwide death rate from hepatobiliary cancers continues to grow, Drs. Karasic and Loaiza-Bonilla explain that research must focus on finding an effective treatment—and immunotherapy could be the answer. 

Read more

January 12, 2017

Dr. Jorge Gallardo and colleagues discuss the epidemiology of esophageal, gastric, liver, gallbladder, pancreatic, colon, and rectal cancers in Chile and how the country’s changing demographics across the past 20 years have increased cancer mortality rates.

Read more
January 12, 2017

How does the location of colon cancer tumors impact clinical decisions?

Read more
January 12, 2017

Drs. Mariela Blum Murphy and Jaffer A. Ajani discuss the latest research on immune checkpoint inhibitors for advanced gastroesophageal cancers.

Read more
January 12, 2017

Dr. Philip highlights several recent and ongoing studies in the field of pancreatic cancer and identifies the biggest hurdles that research must overcome.

Read more

January 12, 2017

Dr. Nina J. Karlin discusses why she continues to attend the GI Cancers Symposium, as well as her advice for first-time attendees.

Read more

January 12, 2017

Drs. Jonathan A. Nowak and Shuji Ogino answer a question about whether it is possible to use molecular assays to distinguishing between hyperplastic polyps and sessile serrated polyps.

Read more